Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4577 USD | -4.65% | +4.98% | -56.42% |
Apr. 24 | Transcript : Evoke Pharma, Inc. - Special Call | |
Mar. 21 | Evoke Pharma, Inc. Announces Board Changes as of March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | 14.08M | Sales 2025 * | 21.9M | Capitalization | 3.88M |
---|---|---|---|---|---|
Net income 2024 * | -3M | Net income 2025 * | 1M | EV / Sales 2024 * | 0.28 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.18 x |
P/E ratio 2024 * |
-1.99
x | P/E ratio 2025 * |
15.3
x | Employees | 4 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 80.62% |
Latest transcript on Evoke Pharma, Inc.
1 day | -4.65% | ||
1 week | +4.98% | ||
Current month | +1.71% | ||
1 month | -25.31% | ||
3 months | -34.66% | ||
6 months | -61.86% | ||
Current year | -56.42% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 54 | 06-12-31 | |
Marilyn Carlson
CTO | Chief Tech/Sci/R&D Officer | 76 | 13-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Cam Garner
FOU | Founder | 75 | 06-12-31 |
Kenneth Widder
BRD | Director/Board Member | 71 | 07-05-31 |
Todd Brady
BRD | Director/Board Member | 52 | 07-05-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-02 | 0.4577 | -4.65% | 22,334 |
24-05-01 | 0.48 | +6.67% | 5,530 |
24-04-30 | 0.45 | +2.27% | 20,260 |
24-04-29 | 0.44 | -3.93% | 41,473 |
24-04-26 | 0.458 | +5.05% | 8,747 |
Delayed Quote Nasdaq, May 02, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-56.42% | 3.88M | |
+29.68% | 681B | |
+21.43% | 556B | |
-4.35% | 361B | |
+17.65% | 325B | |
+3.77% | 285B | |
+13.74% | 235B | |
+4.49% | 199B | |
-12.23% | 189B | |
-3.79% | 157B |
- Stock Market
- Equities
- EVOK Stock